Literature DB >> 29100172

Earlier seizure onset and longer epilepsy duration correlate with the degree of temporal hypometabolism in patients with mesial temporal lobe sclerosis.

Carlos Leiva-Salinas1, Mark Quigg2, W Jeffrey Elias3, James T Patrie4, Lucia Flors5, Nathan B Fountain2, Patrice K Rehm6.   

Abstract

OBJECTIVE: To study the relationship of glucose metabolism and volume of the temporal lobes with age at epilepsy onset, epilepsy duration, and seizure frequency in patients with mesial temporal sclerosis (MTS).
METHODS: We evaluated the pre-surgical 18F-fluoro-deoxyglucose (FDG) positron emission tomography (PET) and magnetic resonance imaging (MRI) of 18 patients with epilepsy and MRI findings of MTS, who were seizure-free for at least 2-years after temporal lobectomy. We calculated the volume of the hippocampi and amygdalae on MRI. On PET we studied their mean standard uptake values (SUV), and relative metabolic activity as compared to normal subjects in terms of Z-scores. We compared the PET and MRI metrics in the bilateral structures using the Wilcoxon sign rank test. We studied the relationship between the imaging metrics and age of epilepsy onset, epilepsy duration, and seizure frequency via Spearman correlation analyses.
RESULTS: Younger age at onset correlated with decreased hippocampal glucose metabolism (rs=0.64, p=0.008). Longer epilepsy duration correlated with decreased hippocampal glucose metabolism (rs=-0.55, p=0.024). There was no correlation between age at onset of epilepsy, epilepsy duration, or seizure frequency and volumetrics. Z-score in the sclerotic hippocampus (-3.51±2.2vs -0.7±1.7) and amygdala (-3.26±2.3 vs -0.68±1.8) was smaller than the contralateral (p<0.001). The diseased hippocampus (2.84±0.49 vs 3.52±0.4ml) and ipsilateral amygdala (1.49±0.24 vs 1.72±0.3ml) were significantly smaller than the contralateral (p<0.02). SIGNIFICANCE: Earlier epilepsy onset correlated with hippocampal hypometabolism. Longer epilepsy duration correlated with amygdalar hypometabolism suggesting an ongoing progressive disease in MTLE.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Duration; Epilepsy; FDG PET; Mesial temporal sclerosis; Metabolism

Mesh:

Substances:

Year:  2017        PMID: 29100172     DOI: 10.1016/j.eplepsyres.2017.10.023

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  5 in total

Review 1.  PET and ictal SPECT can be helpful for localizing epileptic foci.

Authors:  Tim J von Oertzen
Journal:  Curr Opin Neurol       Date:  2018-04       Impact factor: 5.710

Review 2.  Updated Review of the Evidence Supporting the Medical and Legal Use of NeuroQuant® and NeuroGage® in Patients With Traumatic Brain Injury.

Authors:  David E Ross; John Seabaugh; Jan M Seabaugh; Justis Barcelona; Daniel Seabaugh; Katherine Wright; Lee Norwind; Zachary King; Travis J Graham; Joseph Baker; Tanner Lewis
Journal:  Front Hum Neurosci       Date:  2022-04-08       Impact factor: 3.473

3.  AMPK-mediated potentiation of GABAergic signalling drives hypoglycaemia-provoked spike-wave seizures.

Authors:  Kathryn A Salvati; Matthew L Ritger; Pasha A Davoudian; Finnegan O'Dell; Daniel R Wyskiel; George M P R Souza; Adam C Lu; Edward Perez-Reyes; Joshua C Drake; Zhen Yan; Mark P Beenhakker
Journal:  Brain       Date:  2022-07-29       Impact factor: 15.255

4.  Patterns of hypometabolism in frontal lobe epilepsy originating in different frontal regions.

Authors:  Zexian Zhao; Hong Li; Shan Wang; Cong Chen; Chenmin He; Lingli Hu; Zhe Zheng; Junming Zhu; Meiping Ding; Shuang Wang; Yao Ding
Journal:  Ann Clin Transl Neurol       Date:  2022-07-14       Impact factor: 5.430

5.  Continuous monitoring devices and seizure patterns by glucose, time and lateralized seizure onset.

Authors:  Katie M Kinnear; Nicole M Warner; Alan M Haltiner; Michael J Doherty
Journal:  Epilepsy Behav Case Rep       Date:  2018-03-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.